[Clinical usefulness of the new Japanese glomerular filtration rate equation for initial and individualized dosage adjustment concentrations of vancomycin]. 2012

Naoki Kuroda, and Satoshi Ueshima, and Tomoaki Sato, and Eriko Kobiki, and Yoichi Kawasaki, and Hisashi Matsunaga, and Hironori Nakura, and Toshiaki Sendo
Okayama University, 1-1-1 Tsushima-naka, Okayama 700-8530, Japan.

To clarify whether the new Japanese glomerular filtration rate (eGFR) equation was able to accurately determine the initial and individualized dosage adjustment concentrations of vancomycin (VCM), the predictive performance for VCM concentrations using the eGFR and Cockcroft-Gault (CG) equations was compared. Data were retrospectively collected from clinical records of 90 patients with MRSA infection whose trough and peak VCM concentrations had been determined. The predicted VCM initial and individualized dosage adjustment concentrations were performed with the 2-compartment linear model using pharmacokinetic parameter means and their individual values via Bayesian estimation, respectively. The prediction error (PE) and its absolute value (APE) between the observed and predicted VCM concentrations were calculated as indices of bias and accuracy in predictive performance, respectively. In the initial dosage adjustment of VCM, the PE value, calculated with the eGFR equation in trough and peak VCM concentrations of patients whose BMI were 18.5 kg/m(2) and higher, was significantly smaller than that calculated with the CG equation. In particular, both PE and APE values obtained from the eGFR calculated concentrations from nonelderly patients (younger than 65 years old) were significantly improved compared with those from the CG equation. In the individualized dosage adjustment of VCM, the eGFR equation gave a significantly smaller PE value in nonelderly patients' trough concentrations than the CG equation. These findings provide useful information for adjusting the VCM dosage to achieve optimal therapeutic efficacy in patients with MRSA infection.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D005260 Female Females
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections

Related Publications

Naoki Kuroda, and Satoshi Ueshima, and Tomoaki Sato, and Eriko Kobiki, and Yoichi Kawasaki, and Hisashi Matsunaga, and Hironori Nakura, and Toshiaki Sendo
April 2016, Transplantation proceedings,
Naoki Kuroda, and Satoshi Ueshima, and Tomoaki Sato, and Eriko Kobiki, and Yoichi Kawasaki, and Hisashi Matsunaga, and Hironori Nakura, and Toshiaki Sendo
March 2013, Japanese journal of clinical oncology,
Naoki Kuroda, and Satoshi Ueshima, and Tomoaki Sato, and Eriko Kobiki, and Yoichi Kawasaki, and Hisashi Matsunaga, and Hironori Nakura, and Toshiaki Sendo
January 2021, Nephron,
Naoki Kuroda, and Satoshi Ueshima, and Tomoaki Sato, and Eriko Kobiki, and Yoichi Kawasaki, and Hisashi Matsunaga, and Hironori Nakura, and Toshiaki Sendo
April 2005, Annals of internal medicine,
Naoki Kuroda, and Satoshi Ueshima, and Tomoaki Sato, and Eriko Kobiki, and Yoichi Kawasaki, and Hisashi Matsunaga, and Hironori Nakura, and Toshiaki Sendo
April 2005, Annals of internal medicine,
Naoki Kuroda, and Satoshi Ueshima, and Tomoaki Sato, and Eriko Kobiki, and Yoichi Kawasaki, and Hisashi Matsunaga, and Hironori Nakura, and Toshiaki Sendo
April 2005, Annals of internal medicine,
Naoki Kuroda, and Satoshi Ueshima, and Tomoaki Sato, and Eriko Kobiki, and Yoichi Kawasaki, and Hisashi Matsunaga, and Hironori Nakura, and Toshiaki Sendo
October 1999, Annals of internal medicine,
Naoki Kuroda, and Satoshi Ueshima, and Tomoaki Sato, and Eriko Kobiki, and Yoichi Kawasaki, and Hisashi Matsunaga, and Hironori Nakura, and Toshiaki Sendo
October 1999, Annals of internal medicine,
Naoki Kuroda, and Satoshi Ueshima, and Tomoaki Sato, and Eriko Kobiki, and Yoichi Kawasaki, and Hisashi Matsunaga, and Hironori Nakura, and Toshiaki Sendo
October 1999, Annals of internal medicine,
Naoki Kuroda, and Satoshi Ueshima, and Tomoaki Sato, and Eriko Kobiki, and Yoichi Kawasaki, and Hisashi Matsunaga, and Hironori Nakura, and Toshiaki Sendo
May 2009, Annals of internal medicine,
Copied contents to your clipboard!